Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05120869Not ApplicableCompleted

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Role: collaborator

NCT06766279Not ApplicableRecruiting

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

Role: lead

NCT05944575Not ApplicableUnknown

Effect of taVNS on Heart Rate in Persistent Atrial Fibrillation

Role: lead

NCT05243303Not ApplicableRecruiting

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

Role: lead

NCT04177264Not ApplicableUnknown

Anti-inflammatory Actions of Osteopathic Manipulative Treatment

Role: lead

NCT04926415Not ApplicableCompleted

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Role: lead

All 6 trials loaded